Peptyde Tx Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 75.00 K
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Peptyde Tx
Peptyde Tx Private Limited (PTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 25 February 2022 (Two years and 11 months 29 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 75.00 K , as per Ministry of Corporate Affairs (MCA) records.
Akash Mathur, Sasikumar Pottayil, and Ramachandran Radhakrishnan serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA2022PTC158355
- Company No.
158355
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2022
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Peptyde Tx?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sasikumar Pottayil  | Director | 25-Feb-2022 | Current |
| Akash Mathur | Director | 25-Feb-2022 | Current |
| Ramachandran Radhakrishnan | Director | 25-Feb-2022 | Current |
Financial Performance of Peptyde Tx.
Enhance accessibility to Peptyde Tx's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Peptyde Tx?
Unlock access to Peptyde Tx's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avigna Chemitech Private LimitedRamachandran Radhakrishnan is a mutual person
Galoretx Pharmaceuticals Private LimitedSasikumar Pottayil is a mutual person
Svashmi Genotech Private LimitedAkash Mathur and Ramachandran Radhakrishnan are mutual person
- Amethos Pharma Private Limited
Akash Mathur is a mutual person
- Peptis Pharma Llp
Sasikumar Pottayil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Peptyde Tx?
Peptyde Tx has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peptyde Tx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peptyde Tx's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.